title: Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience.
authors.affiliation: Renal Transplant Unit, Hospital Clinic, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Andreu
authors.forename: J M
authors.initials: JM
authors.lastname: Campistol
authors.forename: F
authors.initials: F
authors.lastname: Oppenheimer
authors.forename: V
authors.initials: V
authors.lastname: Torregrosa
authors.forename: M J
authors.initials: MJ
authors.lastname: Ricart
authors.forename: J
authors.initials: J
authors.lastname: Vilardell
authors.forename: P
authors.initials: P
authors.lastname: Carretero
mesh_terms: D000328:Adult; D002985:Clinical Protocols; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy / Q000209:etiology; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology* / Q000401:mortality; D008875:Middle Aged; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate
chemical_list: D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine